OR33-5 Low Systemic Levels of Segesterone Acetate are Required to Inhibit Ovulation in Women

A one-year segesterone acetate (SA)/ethinyl estradiol (EE) contraceptive vaginal system (CVS; Annovera™) used to prevent pregnancy in women of reproductive age, was recently approved by the FDA (August 2018). Efficacy (Pearl Index of 2.98) and safety of the CVS were demonstrated in two phase 3, open...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Endocr Soc
Main Authors: Archer, David, Sitruk-Ware, Regine, Mirkin, Sebastian, Brache, Vivian, Merkatz, Ruth, Kumar, Narender
Format: Artigo
Jezik:Inglês
Izdano: Endocrine Society 2019
Teme:
Reproductive Endocrinology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6554891/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-OR33-5
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki